Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Both low-cost passive ETFs provide exposure to broad European equities but do so via different benchmark indexes.


International diversification is paying off in 2025. As Trump-era tariff threats send U.S. markets tumbling, European equities have held their ground.
A stronger sense of unity across the EU, alongside renewed investment in defense, manufacturing, and technology, has helped insulate the region from broader market volatility.
Investors are also starting to take notice of Europe’s much lower valuations, which have long been ignored in favor of pricier U.S. growth stocks. If you’re interested in European equities but want to reduce exposure to a rising U.S. dollar, check out our piece from on currency-hedged ETF options.
That being said, for low-cost, broadly diversified exposure to the region, U.S. investors largely gravitate towards the Vanguard FTSE Europe ETF

Access Trackinsight's reliable and comprehensive data with 500M+ points on 14,000+ ETFs.
VGK comes out ahead on explicit fees, charging 0.06% compared to IEUR’s 0.09%. On a $10,000 investment, that’s $6 versus $9 annually — not a dealbreaker, but VGK is objectively cheaper.

When it comes to implicit costs, VGK also leads. Its 30-day median bid-ask spread sits at just 0.015%, while IEUR’s is noticeably wider at 0.046%. That difference matters, especially for larger trades or frequent rebalancing, as wider spreads increase trading costs.

Verdict: Add the expense ratio and trading costs together, and VGK comes out as the lower-cost option. It’s cheaper to own and more efficient to trade.
It’s not worth diving too deep into each ETF’s specific benchmark rules — in practice, the differences are minimal and inconsequential for investors.

VGK
Yes, MSCI and FTSE sometimes differ on country and size classifications — for instance, FTSE considers South Korea developed while MSCI classifies it as emerging — but that’s irrelevant here.
Both funds yield around 3% (VGK at 3.19%, IEUR at 3.21%) and concentrate most of their weight in the same countries: the U.K. (post-Brexit, no longer EU), France, Switzerland, and Germany.

Sector exposures are also aligned, led by financials, industrials, healthcare, and consumer discretionary. Top holdings are familiar European multinationals like SAP, Novo Nordisk, Nestlé, AstraZeneca, Roche, Novartis, HSBC, Shell, LVMH, and Siemens.

Thanks to their broad diversification, neither ETF is top-heavy — less than 25% of total assets sit in the top 15 names, something that you don’t see for U.S. equity ETFs.

Verdict: It’s a wash — and pun fully intended. The two ETFs are nearly identical in sector, country, and stock exposure despite tracking different benchmarks, making them suitable tax-loss harvesting substitutes without triggering a wash sale.
Short-term performance has been nearly identical. Over the past three years, one year, and year-to-date, VGK and IEUR have tracked within 1% of each other. Both ETFs have also attracted strong inflows as investors have finally started to appreciate Europe’s relative value.

On the risk side, they’re just as close. Annualized volatility, max drawdown depth, and drawdown duration are virtually the same. It’s yet another sign that despite different benchmark providers, these ETFs behave almost identically — think Coca-Cola vs. Pepsi.

A longer-term backtest from June 12, 2014, to April 3, 2025, shows IEUR with a 4.60% CAGR and VGK just behind at 4.57%. Both posted a Sharpe ratio of 0.24 over that period, meaning they were identical on a risk-adjusted basis.

Verdict: Another tie. Flip a coin. You can expect these ETFs to deliver almost identical performance over time, barring a modest divergence of 100 basis points or less.
Please note that this article reflects the author’s personal views and does not represent the opinions of the publication or its affiliates. It is for informational purposes only and does not constitute investment advice. It is essential to seek guidance from a registered financial professional before making any investment decisions.
Latest ETF News
See all ETF newsThese Industry ETFs Could Be Vulnerable to AI Disruption


Innovations in Swap Based ETFs: Beyond Just Leverage


These Leveraged ETFs are Designed for Long-Term Investors


Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.

What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).

What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).

What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.